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Abstract
Background:  Oxidative modification of low density lipoproteins (LDL) is recognized as one of
the major processes involved in atherogenesis. The in vitro standardized measurement of LDL
oxidative susceptibility could thus be of clinical significance. The aim of the present study was to
establish a method which would allow the evaluation of oxidative susceptibility of LDL in the
general clinical laboratory.
Results:  LDL was isolated from human plasma by selective precipitation with amphipathic
polymers. The ability of LDL to form peroxides was assessed by measuring thiobarbituric acid
reactive substances (TBARS) after incubation with Cu2+ and H2O2. Reaction kinetics showed a
three-phase pattern (latency, propagation and decomposition phases) which allowed us to select
150 min as the time point to stop the incubation by cooling and EDTA addition. The mixture Cu2+/
H2O2 yielded more lipoperoxides than each one on its own at the same time end-point. Induced
peroxidation was measured in normal subjects and in type 2 diabetic patients. In the control group,
results were 21.7 ± 1.5 nmol MDA/mg LDL protein, while in the diabetic group results were
significantly increased (39.0 ± 3.0 nmol MDA/mg LDL protein; p < 0.001).
Conclusion:  a simple and useful method is presented for the routine determination of LDL
susceptibility to peroxidation in a clinical laboratory.
Background
Atherosclerosis is a pathology that affects many people
and may cause their death or disability due to myocardial
infarction or strokes. Although the clinical manifesta-
tions of the disease have been established, the underly-
ing mechanism of atherogenesis is still unclear. Recent
theory points toward the oxidative modification of LDL
(LDL-Ox) as one of the major involved processes [1].
Nevertheless, hardly any of the biological effects of LDL-
Ox have been tested in vivo.
Taking into account the potential clinical importance of
the oxidative modification of LDL, many studies have
been carried out to quantify their in vitro susceptibility to
oxidation. This measurement is thought to correlate with
the LDL oxidative susceptibility within the arterial wall
[2].
Plasmatic LDLs may be isolated by different methods,
which include sequential and density-gradient ultracen-
trifugation, chromatography, electrophoresis and selec-
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complex process that involves the chain reaction of free
radicals with polyunsaturated fatty acids. These reac-
tions lead to rearrangements of double bonds in conju-
gated dienes, hydroperoxide generation, lipid
breakdown into lower molecular weight fragments, as
well as chemical modifications in the apo B protein
[4,5,6,7,8]. The extent of lipid peroxidation can be esti-
mated by measurement of thiobarbituric reactive sub-
stances (TBARS). This method, although nonspecific, is
of value in purified systems. TBARS determination
mainly measures malondialdehyde (MDA) derived from
the hydroperoxidation of unsaturated fatty acids with
three or more double bonds.
Many studies have been carried out to establish the role
of Fe3+, Fe2+ and Cu2+ in the oxidation of LDL [1,8,9]. In
biological systems, the reduction of oxygen yields hydro-
gen peroxide and superoxide radical. The reaction be-
tween these two species generates a hydroxyl radical,
which is the reactive oxygen species with the shortest
half life and highest reactivity. This reaction, which is ki-
netically slow, can be accelerated by catalytic amounts of
iron or copper salts [10].
In the present study we present a simple method which
would allow the high-throughput routine evaluation of
the oxidative susceptibility of LDLs in the simultaneous
presence of Cu2+ and H2O2 in the general clinical labora-
tory. LDLs were isolated by selective precipitation and
their oxidative susceptibility was evaluated through the
quantitation of TBARS.
Results
Optimization of oxidative susceptibility assay
As expressed in Materials and Methods, different vol-
umes of solubilizing solution were used to resuspend
LDL precipitates. Relatively low volumes (0.4 ml) gave
lower intra-assay coefficients of variation (4.8 %) than
relatively high volumes of 1.0 ml (CV = 10.8 %). These re-
sults correspond to the analysis of 22 samples deter-
mined in duplicate. In order to assess the recovery of
standard, a fixed amount of 1.44 nmol MDA / tube was
added to aliquots of previously assayed duplicated resus-
pended LDL samples from three different plasmas. As
can be seen in Table 1 the MDA recovery varied between
78.1 and 93.8 % of the true value.
In experiments aimed at adjusting the number of precip-
itate washes needed, LDL precipitate was washed once
or twice with precipitating solution, or not washed at all,
prior to solubilizing. The protein concentration and cho-
lesterol content of the resulting resuspended LDL sam-
ples was then determined in duplicate. The first wash
diminished the protein content of the resuspended LDL
sample by 20 %, whereas the second wash further de-
creased protein content by 3 %. On the other hand, the
cholesterol content of resuspended LDL samples did not
vary as a consequence of successive washes (99 ± 3 and
98 ± 2 % of non washed precipitate, for 1 or 2 washes re-
spectively). The samples were also submitted to agarose
electrophoresis, and bands revealed with Coomasie bril-
liant blue, in order to evaluate the possible presence of
contaminating plasma proteins. The unwashed precipi-
tate showed a clearly visible band corresponding to albu-
min, as well as another band of greater intensity with the
electrophoretic mobility of LDL. One and two washes
with precipitating reagent greatly diminished - but did
not completely eliminate - the albumin band, without
provoking any changes in the intensity of the LDL band
(data not shown). As the washing procedure eliminates
non-apoB co-precipitating plasma proteins without cho-
lesterol losses, a single wash was selected as the standard
procedure.
Table 1: Recovery of 1.44 nmol MDA/tube added to duplicated re-
suspended LDL samples obtained from three independent plas-
ma samples.
Sample nmol MDA / 
tube in
Observed 
increment
% Recovery
the original 
sample
(nmol MDA/
tube)
mean ± SD
A 0.63 1.15 85 ± 7
0.69 1.30
B 1.07 1.24 78 ± 12
1.32 1.00
C 0.47 1.43 94 ± 8
0.47 1.27
Table 2: Effect of Triton X-100 on the LDL oxidative susceptibility 
assay.
Solubilizing reagent MDA nmol / mg LDL protein
mean ± SD (n = 3)
NaCl 20.3 ± 0.6
NaCl + Triton X-100 21.0 ± 0.7
No significant differences between the two procedures were observed.
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X-100 in the solubilizing solution was evaluated by as-
saying the oxidative susceptibility in three independent
precipitations of the same sample. Two solubilizing rea-
gents were investigated, 50 g/l NaCl and 0.1 % Triton X-
100 in 50 g/l NaCl. Table 2 shows that the same results
for LDL oxidative susceptibility were obtained with the
two procedures. However, since resuspending the pre-
cipitate with Triton X-100 was found to be less time-con-
suming, it was chosen as the standard method.
The kinetics of Cu2+/H2O2-induced LDL peroxidation
was monitored by measuring the TBARS levels in aliq-
uots of three resuspended LDL samples incubated from
15 to 180 min with Cu2+/H2O2 (Figure 1). An initial lag
phase could be observed with no increments in the ab-
sorbance, followed by another with a maximum slope
(propagation phase). A final phase was evident with low-
er absorbance increments (decomposition phase). Fig-
ure 1 represents three examples of various LDL
preparations. In most cases, the propagation phase
reached a maximum at about 150 min. Thus, this incuba-
tion period was selected for the LDL oxidation reaction.
In further experiments, EDTA was validated as an effec-
tive inhibitor of the basal and induced oxidation reac-
tion. After an incubation of 150 min, the results for
samples submitted to oxidation in the presence of EDTA
(30 nmol/tube) monitored for TBARS formation, did not
show significant differences when compared with the
blanks (with Cu2+/H2O2, without sample). Thus, EDTA
at this concentration was subsequently used to effective-
ly stop the oxidative reaction induced by Cu2+/H2O2.
The basal LDL oxidation (as defined in Materials and
Methods) was extremely low and was arbitrary assigned
100 % value (Figure 2). In absence of EDTA and oxidat-
ing agents, the samples showed an inherent oxidability,
with TBARS values of approximately twice that of basal
LDL oxidation. We next analyzed the effect of Cu2+ and/
or H2O2 as inducers of LDL oxidation reaction. When
added separately, Cu2+ and H2O2 increased TBARS for-
mation by approximately 5- fold. However; the simulta-
neous addition of H2O2 and Cu
2+ induced a synergistic
increase in TBARS levels (approximately 13- fold). Dou-
bling doses of Cu2+ or H2O2 did not further increase the
oxidation levels of LDL.
The influence of LDL protein content on the TBARS re-
action, was evaluated by increasing the volume of resus-
pended LDL samples, under constant TBARS reagent
volume and incubation period (Figure 3). The reaction
was linear up to an LDL protein content of approximate-
ly 300 µg/tube.
In order to characterize the LDL isolated by selective pre-
cipitation, and to investigate the possible damage of the
inner structure of LDL caused by this method, we per-
formed an agarose electrophoresis of the resuspended
LDL sample in parallel with the LDL isolated by ultra-
centrifugation and the corresponding whole plasma
sample. As can be seen in Figure 4, LDL fraction isolated
by both methods showed the same electrophoretic mo-
bility and no contamination by other lipoprotein frac-
tions.
LDL oxidation susceptibility in control and diabetic sam-
ples
In order to evaluate the method's usefulness in separat-
ing a control population from another with increased
risk for cardiovascular disease, a group of 30 normal
subjects and 12 type 2 diabetic patients were submitted
to this assay. The oxidative susceptibility of LDL was sig-
nificantly greater in the diabetic group than in the con-
trol population (39.0 ± 3.0 vs. 21.7 ± 1.5 nmol MDA / mg
LDL protein; p < 0.001).
Discussion
The oxidative modification of LDL appears to be in-
volved in the development of various degenerative dis-
Figure 1
Kinetics of in vitro LDL peroxidation assessed by
TBARS formation. An aliquot of 100 µl plasma from three
different patients (A, B, C) was assayed. All sample precipi-
tates were redissolved in 0.4 ml of solubilizing solution, incu-
bated with Cu2+/H2O2 for different periods of time, and 100
µl of oxidized LDL was employed for TBARS assay. Results
are the average of duplicate determinations.
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diabetes mellitus [11,12]. Standard reference methods to
prepare LDL from plasma employ ultracentrifugation.
However, the selective precipitation methods, which are
more accessible than ultracentrifugation, are widely
used in the clinical laboratory for the measurement of
the cholesterol content in different lipoprotein fractions.
In particular, selective precipitation of LDL may be ap-
proached in different ways: by addition of heparin at an
exactly controlled pH of 5.12 in the absence of divalent
cations; or with polyvinylsulphate in the presence of
EDTA and polyethylene glycol methyl ether; with am-
phipathic polymers in imidazole buffer at pH 6.10 (bi-
oMerieux). An excellent statistical correlation is
obtained when these methods are compared with refer-
ence ultracentrifugation methods, providing samples
with triglyceride concentration above 8 mmol/l and
those from patients with hyperlipoproteinemia Type III
are excluded [13]. In particular, the precipitating reagent
used in the present work (bioMerieux), shows a good
correlation coefficient (r = 0.96) when compared with ul-
tracentrifugation methods [3]. Its selectivity and the
preservation of the immunological properties as well as
the lipid composition of the native original LDLs have
also been demonstrated [3,9,14,15]. In our present study,
we were unable to find differences in agarose electro-
phoretic mobility between LDL fractions obtained by
this method of selective precipitation and ultracentrifu-
gation. In addition, no contaminating lipoprotein frac-
tions were observed by this electrophoretic method. In
our standard procedure we washed the LDL precipitate
once prior to solubilizing. Thus, it was necessary to es-
tablish whether there were changes in LDL cholesterol
content, which could invalidate the original method's
correlation with ultracentrifugation. However, we were
unable to find cholesterol losses as a consequence of one
or two washes with precipitating reagent.
Arshad et al. [16] developed a simple method to assess
whole plasma susceptibility to peroxidation by Cu2+/
H2O2 incubation. They used thiobarbituric acid reactivi-
ty to evaluate lipid peroxidation, a method which is not
entirely specific. However, it proved to be easy to per-
form and accessible for the analysis of many samples. In
the present work, we measured LDL-associated TBARS
after induction of lipid peroxidation with a mixture of
Cu2+ and H2O2.
Several methodological aspects of our procedure were
subsequently addressed, in order to achieve its optimiza-
tion. a) The intra-assay precision was found to depend on
the volume of solubilizing solution employed. In our
standard working conditions, the CV was 4.8 %, which is
lower than the precision limit established for the deter-
mination of selectively precipitated lipoprotein choles-
terol (CV < 5%) [3], and so can be considered acceptable.
b) The observed percentage of recovery for exogenously
added MDA (Table 1) was comparable to that of the
TBARS reaction (82-100 %) [10]. These results suggest
that the additioned MDA was still TBA reactive and did
not generate any interfering substances, since the ob-
served increment in MDA content did not significantly
differ from that of the true value. c) It is important to en-
sure that the precipitate is not contaminated with non-
LDL serum proteins, since results are expressed per LDL
protein content. This contribution to variability was
eliminated by washing the LDL precipitate. d) When the
composition of the solubilizing solution was evaluated,
precipitate redissolution effectively occurred in 50 g/l
NaCl. However, the addition of Triton X-100 was chosen
because it shortened the period of LDL redissolution. e)
Lipid peroxidation kinetics have been extensively stud-
ied [8,10]. It is known that LDL oxidation in the presence
of Cu2+ shows three phases: latency, propagation and de-
composition. This has been established by determina-
tion of hydroperoxides, TBARS or other aldehydes,
fluorescent products and conjugated dienes. It has been
shown that during the latency and propagation phases,
as well as during the early stages of the decomposition
phase, the time-courses of diene, TBARS and lipid hy-
droperoxide formation, are practically coincident [8]. In-
Figure 2
Basal and Cu2+ and H2O2 -induced LDL oxidation.
Samples were incubated with EDTA (basal LDL oxidation),
without additions, or in the presence of Cu2+ (100 µM) and/
or H2O2 (300 ml/l). Results are expressed as % basal TBARS
values.
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However, each individual's LDL shows its own particular
kinetics so that sample to sample variations could repre-
sent a problem when - as in the present study - a single
measurement of only one parameter is taken after a long
incubation time. This does not allow us to conclusively
establish whether the sample is at the end of its propaga-
tion phase, or has already begun its decomposition
phase. In our preliminary studies of TBARS time-course,
we found a lag phase followed by a maximum slope
which ended at 150 min, the time point adopted for our
standard procedure. A slower increment in absorbance
was observed from this point on, a fact that may have
been due to the decomposition of accumulated products.
f) In the absence of oxidation inhibitors, LDL oxidation
may continue throughout the TBA reaction period, thus
contributing to the method's variability. This was effec-
tively prevented by the addition of EDTA prior to the
TBA reaction, which acts as an inhibitor of LDL oxida-
tion by Cu2+ sequestration. g) Our experiments show
that the combination of Cu2+ and H2O2 is more effective
for the induction of LDL oxidation, than each agent its
own. The observed results suggest a synergistic mecha-
nism of action between both reagents. Previous studies
have addressed the Cu2+-induced in vitro oxidation of
plasma LDL [17]. These authors found a value of 21 ± 3
nmol MDA / mg LDL protein, obtained from four normal
subjects, for LDL isolated by ultracentrifugation. This is
practically coincident with the results which we obtained
with our control healthy population (21.7 ± 1.5 nmol
MDA / mg LDL protein), as would be expected from the
reported correlation between LDL obtained by ultracen-
trifugation and by the LDL-precipitating method of bi-
oMerieux. Recently, Guerci et al.[14] studied the LDL
oxidation susceptibility of normolipidemic diabetic and
non-diabetic patients. These authors found a significant
increase in type 2 diabetic patients vs. healthy subjects,
particularly in the group of type 2 diabetic females, in
which LDL oxidation susceptibility was highest. In coin-
cidence with these reported results, LDL oxidative sus-
ceptibility of our type 2 diabetic patients was
significantly greater (39.0 ± 3.0 nmol MDA / mg LDL
protein) than the control group.
The LDL precipitation method which we have used in
this study is based on interaction with glycosaminogly-
cans (GAG). However, both lipid composition and the
content of sialic acid can modulate the interaction with
GAG. In this context, particles such as small dense LDL
can interact with GAG with high affinity. In addition, the
precipitation procedure may increase the susceptibility
for oxidation by copper since copper penetrates the LDL
particle more easily after precipitation. In consequence,
we cannot discard the possibility that our results may re-
flect a preselection of LDL with higher susceptibility for
oxidation.
Figure 3
Influence of the LDL protein content on TBARS
reaction linearity. Increasing doses of a LDL sample were
submitted to constant oxidative conditions. Results are
expressed as mean of duplicate determinations. y = 4.35 . 10-
3 × - 6.57 . 10-3, r2 = 0.994; p < 0.001.
Figure 4
Agarose electrophoresis of whole plasma and LDL
fractions. Bands correspond to: 1, LDL fraction obtained by
selective precipitation; 2, whole plasma of a normolipidemic
patient; 3, whole plasma of a hyperlipidemic patient; 4, LDL
fraction obtained by ultracentrifugation. Samples were
stained with Sudan black.
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A simple method for the in vitro measurement of LDL
oxidation susceptibility has been optimized, and applied
to a group of healthy subjects and type 2 diabetic pa-
tients. This straightforward approach could facilitate the
comparison of results obtained from an increased
number of general clinical laboratories, and thus allow
us to move a step further towards the standardization of
a procedure of potential clinical importance.
Materials and methods
Materials
LDL Cholesterol kit (cat. Number 61532) was provided
by bioMerieux (Marcy l'Etoile France). Hydragel
Lipo+Lp(a) kit for agarose electrophoresis was obtained
from Sebia. Thiobarbituric acid was obtained from Mer-
ck. 1,1',3,3'- tetra-methoxy-propane or malondialdehyde
(MDA) was used as standard and purchased from SIG-
MA Co. St. Louis, MO, USA. All chemicals were of analyt-
ical grade and used without further purification.
Sample collection
Twelve type 2 diabetic patients of both sexes (37 - 65
years old) were studied. The degree of metabolic control
was assessed by the measurement of fasting plasma glu-
cose (mean 7.2 ± 1.1 mmol/l), fasting plasma HbA1c
(mean 6.8 ± 1.3 %; NV 4.8-6.0 %) and they were normo-
lipidemic. A series of 30 control non-diabetic subjects of
both sexes (age range, 35-60 year old) was processed in
parallel. All controls were normolipidemic according to
the Alfedian criteria [18], and none of the subjects were
taking any drug known to influence lipid or lipoprotein
metabolism. Blood samples were obtained on heparin (5
U/ml) by venipuncture from subjects with 12 hours fast-
ing. Plasma was separated rapidly and processed imme-
diately. Alternatively, the samples were stored at 4 ºC for
24 hours or at -20º C for not more than 2 days.
Method of LDL isolation
LDL was selectively precipitated from 100 µl of plasma
by addition of bioMerieux precipitating reagent of LDL-
Cholesterol kit and vortex-mixed [14]. The mixture was
incubated for 30 min at 2-8 ºC, and centrifuged for 5
min. The supernatant was discarded and the precipitate
was washed with precipitating reagent. The washed pre-
cipitate was redissolved in different volumes of solubiliz-
ing solution (0.01% Triton X100 in 50 g/l NaCl) at 37 ºC,
and vortex-mixed (resuspended LDL sample) [15]. Brad-
ford's method [19] was used to determine the total pro-
tein content of the resuspended LDL sample, using
bovine serum albumin as a standard. For selected exper-
iments, the LDL fraction was obtained by density gradi-
ent ultracentrifugation as has been previously described
[13].
Characterization of LDL isolated by selective precipitation
Representative samples were subjected to ultracentrifu-
gation and selective precipitation (0, 1 or 2 washes) in or-
der to isolate the LDL fraction. Subsequently, LDL
fractions obtained by both methods, as well as the whole
plasma, were electrophoresed in agarose according to
the manufacturer's instructions. Briefly, electrophoresis
was performed at a constant voltage of 130 V and initial
intensity of 25 mA, for 80 minutes. The gel was dried and
bands were revealed with either Sudan Black or Cooma-
sie brillant blue.
LDL-cholesterol determination
LDL was obtained by selective precipitation of represent-
ative samples, and the resulting precipitates were
washed once, twice, or not at all with the precipitating re-
agent, prior to resuspending with the solubilizing solu-
tion. Cholesterol content of the resulting resuspended
LDL samples was determined by a commercial enzymat-
ic kit (Colestat, Wiener Laboratories Argentina).
Basal and induced LDL oxidation
Basal LDL oxidation was determined by incubating an
aliquot of 100 µl resuspended LDL sample, containing
50-90 µg protein, with 30 µl of 1 mM EDTA and 45 µl of
distilled water. The corresponding blank was determined
substituting the resuspended LDL sample by solubilizing
solution.
In other experiments, resuspended LDL sample was
mixed with 50 µl of 100 µM Cu2+ (freshly prepared in
phosphate buffer saline solution, PBS, pH 7.4) and 25 µl
of H2O2 solution (300 ml/l H2O2 in PBS, stock solution
corresponds to 10 volume commercial H2O2). Blank was
performed with solubilizing solution instead of resus-
pended LDL sample. In all cases, sample and blank were
incubated at 37 ºC for different periods of time with oc-
casional stirring. At the end of the incubation period, the
lipid peroxidation was stopped by cooling and addition
of 30 µl of 1 mM EDTA.
TBARS determination
Lipid peroxidation of LDL was assessed by TBARS for-
mation [20]. Briefly, samples were incubated with 0.5 ml
of 20% acetic acid, pH 3.5 and 0.5 ml of 0.78% aqueous
solution of thiobarbituric acid. After heating at 95 °C for
45 minutes, the samples were centrifuged at 4000 r.p.m.
for 5 minutes. The red pigment in the supernatant frac-
tions was estimated by absorbance at 532 nm. A calibra-
tion curve was prepared with an MDA standard. Results
were expressed as nmol MDA /mg LDL protein. All sam-
ples gave results which were within the linear portion of
the MDA standard curve. A recovery assay was also per-
formed by adding a defined amount of MDA before incu-
bating with the oxidant mixture.
BMC Clinical Pathology (2001) 1:1 http://www.biomedcentral.com/1472-6890/1/1Statistical analysis
Results were expressed as mean ± SD and mean ± SEM.
Statistical analysis was performed by Student's t test; a p
value < 0.05 was considered statistically significant. Lin-
ear regression analysis was used for testing correlations
between variables.
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